NDC properties for "testosterone 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT" (RxCUI 1596781)
About this data
The tables show NDC propoerties for testosterone 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT with the RxCUI 1596781
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for testosterone 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT (RxCUI 1596781)
| ANDA | ANDA204571 |
|---|---|
| MMSL_CODE | BD26780 |
| MMSL_CODE | CD26780 |
| RxCUI | 1596781 |
| SPL_SET_ID | 415057d5-8ed3-42dd-9637-05145c84a9c2 |
| VUID | 4030472 |
| Prescribable Synonym | testosterone 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT |
| RXNAV_STR | 120 ACTUAT testosterone 10 MG/ACTUAT Topical Gel |
| RxNorm Name | 120 ACTUAT testosterone 10 MG/ACTUAT Topical Gel |
| RxNorm Synonym | testosterone 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT |
| Related queries | Interactions (for RxCUI 1596781) |
NDC Properties
NDC Item 00591236360
| NDC 9 | 0591-2363 |
|---|---|
| NDC 10 | 0591-2363-60 |
| NDC Item | 00591236360 |
| Packaging | 1 CANISTER in 1 CARTON (0591-2363-60) / 60 g in 1 CANISTER |
| ANDA | ANDA204571 |
| DCSA | CIII |
| FDA SPL set id | 673485 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2015-06-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2363 |
NDC Item 00603783188
| NDC 9 | 0603-7831 |
|---|---|
| NDC 10 | 0603-7831-88 |
| NDC Item | 00603783188 |
| Packaging | 1 CANISTER in 1 CARTON (0603-7831-88) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 725472 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2014-08-25 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021463 |
| Related queries | Properties for NDC 9 0603-7831 |
NDC Item 00591236360
| NDC 9 | 0591-2363 |
|---|---|
| NDC 10 | 0591-2363-60 |
| NDC Item | 00591236360 |
| Packaging | 1 CANISTER in 1 CARTON (0591-2363-60) / 60 g in 1 CANISTER |
| ANDA | ANDA204571 |
| DCSA | CIII |
| FDA SPL set id | 673485 |
| Labeler | Actavis Pharma, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2025-11-30 |
| Marketing effective time low | 2015-06-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0591-2363 |
NDC Item 00603783188
| NDC 9 | 0603-7831 |
|---|---|
| NDC 10 | 0603-7831-88 |
| NDC Item | 00603783188 |
| Packaging | 1 CANISTER in 1 CARTON (0603-7831-88) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 725472 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-02-28 |
| Marketing effective time low | 2014-08-25 |
| Marketing status | COMPLETED |
| NDA_AUTHORIZED_GENERIC | NDA021463 |
| Related queries | Properties for NDC 9 0603-7831 |